Implant Developments for Spinal Cord Injuries Promise Potential Recovery Advancements
The latest advancements in spinal cord implantable electronic devices are revolutionising the treatment of spinal cord injuries (SCIs). Recent animal studies, particularly in rats, have demonstrated promising results in restoring movement and sensation through these devices.
Key developments include:
- **Ultra-thin implant design:** The implants, such as the one developed by the University of Auckland and Chalmers University of Technology, are designed to be extremely thin and flexible, allowing them to sit directly on the spinal cord at the injury site without causing discomfort or damage. This design minimises inflammation and avoids an immune response, making long-term implantation safer and more comfortable for patients.
- **Electric field (EF) therapy:** The devices deliver low-frequency alternating current (around 2 Hz) that stimulates nerve fiber (axon) regeneration and the formation of new connections across the injury site. This mimics natural electrical guidance systems that support nervous system development.
- **Enhanced electrodes with conductive polymers:** Researchers are working on implants with larger electrodes made from materials like PEDOT, a conductive polymer, which allows for higher charge densities without compromising biocompatibility. This enables delivering stronger and more effective stimulation pulses while reducing inflammation and safety risks.
- **Energy efficiency and extended stimulation periods:** New systems use alternating polarity stimulation, which is more energy efficient and requires only a fraction of the power used by previous implant-based treatments. This low power demand opens possibilities for powering the implant through body movements or piezoelectronics, potentially eliminating the need for batteries. Longer stimulation sessions are now possible without tissue damage.
- **Preclinical success in rodent models:** Studies have shown that daily low-frequency EF treatment via these implants led to significant recovery in motor function in rats with spinal injuries. The improvements include motion and sensation, indicating that the therapy supports axon regrowth and improves neural communication across damaged spinal tissue.
- **Future clinical applications:** Researchers envision temporary or biodegradable implants for early post-injury intervention in humans, aiming to promote axon regrowth and reduce secondary damage following spinal cord injuries. Trials are planned in larger animal models to refine treatment protocols and further understand the mechanisms of recovery facilitated by the implants.
The implant's electrodes, coated in sputtered iridium oxide films (SIROF), diffuse into the surrounding tissue without causing inflammation. The device improves electrical pulse penetration while lowering energy consumption. Treated rats showed improved performance on a variety of motor skill tests, alongside greater cell counts in motor-related brain regions.
It is estimated that an additional 200-500K people will suffer from SCIs this year. It could take 7-10 years before the technology begins to make its way into the medical field officially. The University of Auckland has demonstrated progress towards creating an implantable electronic device designed to enable those suffering from spinal cord injury to recover functionality.
The new cathodes used in the implant outperform their predecessors by 1000X, allowing for longer stimulation periods. The implant uses only a fraction of the energy required by other implant-based treatments, making it energy efficient. The implant's alternating charge every 15 minutes was found to be safe and effective, delivering stronger doses without harming the patient. The team of researchers behind the implant includes Dr. Bruce Harland, Professor Darren Svirskis, Maria Asplund, and several other scientists from accredited universities. The implant does not produce harmful by-products or side effects after the implant, allowing for more frequent treatment with less risk.
These advancements bring the field closer to effective, safe, and possibly non-invasive treatments for spinal cord injury patients. The implant's ultrathin design, electric field therapy, enhanced electrodes with conductive polymers, energy efficiency, and safety make it a promising solution for those affected by SCIs.
The ultrathin implant design, coated in sputtered iridium oxide films, is showing great promise for those suffering from spinal cord injuries (SCIs) by improving electrical pulse penetration while lowering energy consumption. Furthermore, this advancement in health and wellness technology could offer effective, safe, and possibly non-invasive treatments for those dealing with medical-conditions like chronic-diseases related to SCIs.
